235 related articles for article (PubMed ID: 30045335)
1. Prognostic significance of lymph node ratio in node-positive cervical cancer patients.
Joo JH; Kim YS; Nam JH
Medicine (Baltimore); 2018 Jul; 97(30):e11711. PubMed ID: 30045335
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
[TBL] [Abstract][Full Text] [Related]
3. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
Kwon J; Eom KY; Kim YS; Park W; Chun M; Lee J; Kim YB; Yoon WS; Kim JH; Choi JH; Chang SK; Jeong BK; Lee SH; Cha J
Cancer Res Treat; 2018 Jul; 50(3):964-974. PubMed ID: 29081219
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
Jung W; Kim K; Kim J; Shim SJ
In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
8. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
Fan X; Wang Y; Yang N; Zhu P
World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
11. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.
Fleming ND; Frumovitz M; Schmeler KM; dos Reis R; Munsell MF; Eifel PJ; Soliman PT; Nick AM; Westin SN; Ramirez PT
Gynecol Oncol; 2015 Jan; 136(1):48-53. PubMed ID: 25451695
[TBL] [Abstract][Full Text] [Related]
13. Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?
Bharath VM; Balagopal PG; Nebu AG; Jayasudha AV; Iqbal Ahmed M; Sebastian P
Gulf J Oncolog; 2018 Sep; 1(28):6-10. PubMed ID: 30344127
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
15. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Ratio Can Better Predict Prognosis than Absolute Number of Positive Lymph Nodes in Operable Cervical Carcinoma.
Widschwendter P; Polasik A; Janni W; de Gregorio A; Friedl TWP; de Gregorio N
Oncol Res Treat; 2020; 43(3):87-95. PubMed ID: 31935729
[TBL] [Abstract][Full Text] [Related]
17. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
18. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
19. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
